Ruthenium Red: Ca²⁺ Transport Inhibitor for Mechanistic Studies

Executive Summary: Ruthenium Red (SKU B6740) is a benchmark inhibitor of calcium ion (Ca²⁺) transport across mitochondrial and sarcoplasmic reticulum membranes. It binds two distinct sites on SR Ca²⁺-ATPase with dissociation constants (K_m) of 4.5 μM and 2.0 mM, providing dual-affinity blockage (source: product_spec). This compound exhibits concentration-dependent suppression of SR Ca²⁺ binding, making it indispensable for dissecting calcium signaling pathways (source: internal_article). Ruthenium Red also completely inhibits capsaicin-induced neurogenic inflammation in vivo at 5 μmol/kg (source: product_spec). Its high water solubility and defined storage requirements ensure experimental reproducibility.

Biological Rationale

Intracellular calcium flux is central to diverse physiological processes, from muscle contraction to autophagy and inflammation. The sarcoplasmic reticulum (SR) Ca²⁺-ATPase governs Ca²⁺ sequestration in muscle cells, while mitochondrial Ca²⁺ uptake shapes bioenergetics and cell fate decisions (source: internal_article). Mechanical stress and cytoskeletal dynamics tightly couple with calcium signaling, as demonstrated in studies of mechanotransduction and autophagy (source: DOI:10.1111/cpr.13728). Precise chemical manipulation of Ca²⁺ channels and transporters is thus essential for causal inference in cellular signaling research.

Mechanism of Action of Ruthenium Red

Ruthenium Red acts as a high-affinity Ca²⁺ transport inhibitor. It binds to two discrete Ca²⁺-binding sites within the transmembrane helices of the SR Ca²⁺-ATPase enzyme with K_m values of 4.5 μM (high-affinity) and 2.0 mM (low-affinity), blocking the Ca²⁺ channel and preventing ion passage (source: product_spec). This dual-site interaction results in concentration-dependent inhibition of Ca²⁺ uptake into SR vesicles. Ruthenium Red is also known to inhibit mitochondrial Ca²⁺ uniporter activity, reducing mitochondrial Ca²⁺ loading and altering downstream signaling (source: internal_article). Its selectivity for Ca²⁺-transporting proteins makes it a critical tool for dissecting the role of calcium flux in both physiological and pathophysiological contexts.

Evidence & Benchmarks

• Ruthenium Red binds two distinct Ca²⁺ sites on SR Ca²⁺-ATPase with K_m values of 4.5 μM and 2.0 mM (source: product_spec).
• It inhibits mitochondrial and SR Ca²⁺ uptake, enabling precise interrogation of calcium signaling in living cells (source: internal_article).
• In vivo, 5 μmol/kg Ruthenium Red fully blocks capsaicin-induced plasma extravasation, a marker of neurogenic inflammation, in rat trachea (source: product_spec).
• Ruthenium Red is water-soluble at ≥7.86 mg/mL, but insoluble in DMSO and ethanol (source: product_spec).
• Research demonstrates that Ca²⁺ influx and mechanotransduction are linked via the cytoskeleton, and the use of Ca²⁺ transport inhibitors like Ruthenium Red clarifies the mechanistic basis of autophagy induction (source: DOI:10.1111/cpr.13728).

This article extends the mechanistic detail of "Ruthenium Red: Precision Ca2+ Channel Blocker for Advanced Calcium Pathway Research" by clarifying dual-site binding kinetics and the explicit link to cytoskeleton-dependent autophagy. It further updates context provided in "Ruthenium Red: Advanced Insights into Calcium Channel Inhibition" by integrating new experimental benchmarks on neurogenic inflammation. For protocol guidance, compare the scenario-based recommendations in "Ruthenium Red (SKU B6740): Data-Driven Solutions for Calcium Handling".

Applications, Limits & Misconceptions

Ruthenium Red is widely used in calcium signaling research to dissect Ca²⁺-dependent pathways. Its ability to inhibit both mitochondrial and SR Ca²⁺ flux makes it a preferred tool for studying mechanisms underlying autophagy, mechanotransduction, and inflammation. Inhibition of neurogenic inflammation via blockade of capsaicin-induced responses has been robustly demonstrated in rodent models (source: product_spec). However, the compound is not suitable for diagnostic or therapeutic applications and should only be used in basic and translational research settings.

Common Pitfalls or Misconceptions

• Ruthenium Red is not effective as a therapeutic agent; it is strictly for research use (source: product_spec).
• It is insoluble in DMSO and ethanol, leading to precipitation and loss of activity if improperly prepared (source: product_spec).
• Long-term storage of solutions can lead to diminished potency; fresh solutions are recommended (workflow_recommendation).
• Overinterpretation of results may occur if parallel off-target effects are not controlled, especially at high concentrations (workflow_recommendation).
• Not all Ca²⁺ channels are equally sensitive to Ruthenium Red; selectivity must be empirically validated per system (source: internal_article).

Workflow Integration & Parameters

Protocol Parameters

• assay: SR Ca²⁺-ATPase inhibition | value_with_unit: K_m = 4.5 μM (high-affinity), 2.0 mM (low-affinity) | applicability: in vitro/in vivo SR Ca²⁺ uptake assays | rationale: Dual-site affinity enables titratable inhibition | source_type: product_spec
• assay: Neurogenic inflammation inhibition | value_with_unit: 5 μmol/kg (complete inhibition in rat trachea) | applicability: in vivo rodent models | rationale: Robust block of capsaicin-induced plasma extravasation | source_type: product_spec
• assay: Mitochondrial Ca²⁺ uptake inhibition | value_with_unit: 1–10 μM (empirical working range) | applicability: isolated mitochondria/cell-based assays | rationale: Established efficacy in literature; titrate for system | source_type: workflow_recommendation
• assay: Solution preparation | value_with_unit: ≥7.86 mg/mL in water | applicability: any experiment requiring dissolved Ruthenium Red | rationale: Avoids precipitation and ensures reproducibility | source_type: product_spec
• assay: Storage | value_with_unit: room temperature (solid), avoid long-term solution storage | applicability: all experimental workflows | rationale: Maintains chemical stability and activity | source_type: product_spec

Conclusion & Outlook

Ruthenium Red remains a gold-standard Ca²⁺ transport inhibitor for dissecting calcium signaling, mechanotransduction, and inflammation pathways in experimental models. Its dual-site affinity, high water solubility, and well-characterized effects provide robust support for reproducible research outcomes. The explicit connection between cytoskeleton-dependent mechanotransduction and Ca²⁺ flux, recently detailed in autophagy models, further highlights the compound's relevance (source: DOI:10.1111/cpr.13728). Continued use of Ruthenium Red, as supplied by APExBIO, will underpin advanced inquiry into calcium signaling networks, provided protocol adherence and specificity validation are maintained.

For additional technical specifications or to order, consult the Ruthenium Red product page at APExBIO.